Sfoglia per Autore
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA)
2018 Taramasso, L; Tatarelli, P; Ricci, E; Madeddu, G; Menzaghi, B; Squillace, N; De Socio, G; Martinelli, C; Gulminetti, R; Maggi, P; Orofino, G; Vichi, F; Di Biagio, A; Bonfanti, P; Bellacosa, C; Calza, L; Abeli, C; Celesia, B; Grosso, C; Stagno, A; Mazzotta, F; Penco, G; Cassola, G; Nicolini, L; Dentone, C; Molteni, C; Palvarini, L; Scalzini, A; Carenzi, L; Rizzardini, G; Valsecchi, L; Cordier, L; Rusconi, S; Colombo, V; Galli, M; Franzetti, M; Sgrelli, A; Mazzotta, E; Parruti, G; Bagella, P; Mura, M; Libertone, R; Antinori, A; Di Giambenedetto, S; Guastavigna, M; Caramello, P
Weight gain: A possible side effect of all antiretrovirals
2017 Taramasso, L; Ricci, E; Menzaghi, B; Orofino, G; Passerini, S; Madeddu, G; Martinelli, C; De Socio, G; Squillace, N; Rusconi, S; Bonfanti, P; Biagio, A; Quirino, T; Bellacosa, C; Maggi, P; Calza, L; Abeli, C; Celesia, B; Grosso, C; Stagno, A; Vichi, F; Mazzotta, F; Penco, G; Cassola, G; Taramasso, L; Nicolini, L; Dentone, C; Molteni, C; Palvarini, L; Scalzini, A; Carenzi, L; Rizzardini, G; Valsecchi, L; Cordier, L; Colombo, V; Galli, M; Franzetti, M; Mazzotta, E; Parruti, G; Bagella, P; Mura, M; Libertone, R; Antinori, A; Di Giambenedetto, S; Guastavigna, M
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project
2017 Squillace, N; Ricci, E; Quirino, T; Gori, A; Bandera, A; Carenzi, L; De Socio, G; Orofino, G; Martinelli, C; Madeddu, G; Rusconi, S; Maggi, P; Celesia, B; Cordier, L; Vichi, F; Calza, L; Falasca, K; Di Biagio, A; Pellicano, G; Bonfanti, P
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?
2017 Taramasso, L; Ricci, E; Celesia, B; Bonfanti, P; Quirino, T; Squillace, N; Nicolini, L; Maggi, P; Martinelli, C; De Socio, G; Di Biagio, A
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir
2017 Bonfanti, P; Madeddu, G; Gulminetti, R; Squillace, N; Orofino, G; Vitiello, P; Rusconi, S; Celesia, B; Maggi, P; Ricci, E
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients
2017 Fabbiani, M; Muscatello, A; Perseghin, P; Bani, M; Incontri, A; Squillace, N; Lapadula, G; Gori, A; Bandera, A
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort
2016 Squillace, N; Galli, L; Bandera, A; Castagna, A; Madeddu, G; Caramello, P; Antinori, A; Cattelan, A; Maggiolo, F; Cingolani, A; Gori, A; Monforte, A
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART
2016 Squillace, N; Lorenzini, P; Lapadula, G; Bandera, A; Cozzi-Lepri, A; Rusconi, S; Puoti, M; Castagna, A; Antinori, A; Gori, A; d'Arminio Monforte, A
Brachial and central blood pressure in HIV-infected subjects
2015 Maloberti, A; Dozio, D; Betelli, M; Bandera, A; Squillace, N; Gori, A; Castoldi, G; Stella, A; Mancia, G; Giannattasio, C
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial
2015 Soria, A; Trabattoni, D; Squillace, N; Rainone, V; Gnudi, F; Clerici, M; Gori, A; Bandera, A
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy
2015 Soria, A; Limonta, S; Leone, S; Muscatello, A; Squillace, N; Bandera, A; Gori, A
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients
2014 Squillace, N; Bresciani, E; Torsello, A; Bandera, A; Sabbatini, F; Giovannetti, C; Giunta, G; Rovati, L; Del Bene, M; Locatelli, V; Gori, A
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk?
2014 Mangioni, D; Muscatello, A; Sabbatini, F; Soria, A; Rossi, M; Bisi, L; Squillace, N; De Grandi, C; Gori, A; Bandera, A
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects
2013 Maloberti, A; Betelli, M; Villa, P; Dozio, D; Cesana, F; Bandera, A; Squillace, N; Gori, A; Grassi, G; Giannattasio, C
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir
2013 Bandera, A; Trabattoni, D; Squillace, N; Muscatello, A; Calascibetta, F; Maloberti, A; Giannattasio, C; Marcandalli, V; Clerici, M; Gori, A
Unmasking tuberculosis in the era of antiretroviral treatment
2012 Lapadula, G; Soria, A; Bandera, A; Squillace, N; Sabbatini, F; Franzetti, F; Migliori, G; Gori, A
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS?
2011 Soria, A; Airoldi, M; Migliorino, G; Squillace, N; Bandera, A; Lapadula, G; Gori, A
Arterial structure and function in AIDS patients: the impact of renal damage.
2010 Capra, A; Giannattasio, C; Failla, M; Citterio, F; Dozio, D; Nava, S; Cairo, M; Corciulo, M; Maloberti, A; Gori, A; Sabbatini, F; Squillace, N; Castoldi, G; Mariani, A; Stella, A; Mancia, G
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study
2008 Squillace, N; Lapadula, G; Torti, C; Orlando, G; Mandalia, S; Nardini, G; Beghetto, B; Costarelli, S; Guaraldi, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile